SEC Form D private-offering filing

BioLoomics, Inc.

A new SEC Form D private-offering notice from Boulder, CO, a $2,000,000 filer-stated offering target in Biotech. The source filing is one click away.

BioLoomics, Inc. site↗ Verified via SEC Form D

Preclinical biotech developing next generation antibody drug conjugates (ADCs) for cancer therapy

Filed 2025-11-10Filed to raise $2,000,000First money in 2025-08-11Raised so far $450,000HQ (as filed) Boulder, COSector Biotech ✓Stage (inferred) SeedCall status Late filing
Source linked the Form D on EDGAR↗Website verified bioloomics.com↗Named in the filing 3 executives & directors
Open this row on the live feed →More new filings in Colorado →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.